Recently, we published a prediction rule for the development of arthritis in rheumatoid factor (RF) and/or anti-citrullinated protein antibodies (ACPA) positive (seropositive) arthralgia patients [1]. This evidence concerns the gene PRTN3 and Arthralgia.